The Journal of Bone and Joint Surgery, Vol 77, Issue 6 828-834, Copyright © 1995 by Journal of Bone and Joint Surgery, Inc
Hip arthroplasty in hemophilic arthropathy
SS Kelley, PF Lachiewicz, MS Gilbert, ME Bolander and JJ Jankiewicz
Mayo Clinic, Rochester, Minnesota 55905, USA.
As hemophilic arthropathy infrequently affects the hip joint, we performed
a multicenter retrospective study to determine the results of hip
arthroplasty in hemophilic patients. Thirty-four hip arthroplasties were
performed in twenty-seven male patients at four major hemophilia centers
from October 1972 through September 1990. Twenty-six patients had classic
hemophilia and one had factor-IX deficiency. The mean age of the patients
at the time of the operation was thirty-eight years (range, fifteen to
seventy-three years). The mean duration of follow-up was eight years, with
a minimum of two years for all patients who were still alive at the time of
this review. Four patients were seropositive for the human immunodeficiency
virus at the time of the operation, and sixteen patients were seropositive
at the time of the most recent follow-up examination. Nine patients (33 per
cent) died before the time of this review; seven had been seropositive for
the human immunodeficiency virus. There were twenty-six total hip
arthroplasties performed with cement, six total hip arthroplasties
performed without cement, one total hip arthroplasty in which the femoral
component was inserted with cement and the acetabular component was
inserted without it (so-called hybrid arthroplasty), and one bipolar
arthroplasty performed with cement. There were no early infections after
these thirty-four primary arthroplasties. There were three late infections
around prostheses inserted with cement, and all led to a resection
arthroplasty. Six (21 per cent) of the twenty-eight cemented femoral
components and six (23 per cent) of the twenty-six cemented acetabular
components were revised because of aseptic loosening.(ABSTRACT TRUNCATED AT
250 WORDS)